First-trimester ductus venosus screening for cardiac defects: A meta-analysis

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 118, Issue 12, 2011, Pages 1438-1445

  Papatheodorou, S I ^a   Evangelou, E ^a   Makrydimas, G ^a   Ioannidis, J P A ^a,b  

^a UNIVERSITY OF IOANNINA   (Greece)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chromosomal abnormalities; congenital heart disease; ductus venosus; nuchal translucency

Indexed keywords

CHROMOSOME ABERRATION; CONGENITAL HEART DISEASE; CONGENITAL HEART MALFORMATION; DIAGNOSTIC ACCURACY; DOPPLER ECHOCARDIOGRAPHY; DUCTUS VENOSUS; FIRST TRIMESTER PREGNANCY; HUMAN; META ANALYSIS; NUCHAL TRANSLUCENCY MEASUREMENT; PRIORITY JOURNAL; REVIEW; SCREENING; SENSITIVITY AND SPECIFICITY;

FEMALE; FETAL HEART; HEART DEFECTS, CONGENITAL; HUMANS; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY; PREGNANCY TRIMESTER, FIRST; SENSITIVITY AND SPECIFICITY; ULTRASONOGRAPHY, PRENATAL;

EID: 80054014607     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2011.03029.x     Document Type: Review

References (34)

1. Mitchell SC, Korones SB,. Congenital heart disease in 56109 births. Incidence and natural history. Circulation 1971; 43: 323-32.
2. Montenegro N, Matias A, Areias JC, Castedo S, Barros H,. Increased fetal nuchal translucency: possible involvement of early cardiac failure. Ultrasound Obstet Gynecol 1997; 10: 265-8. (Pubitemid 27485323)
3. Matias A, Montenegro N, Areias JC, Brandao O,. Anomalous fetal venous return associated with major chromosomopathies in the late first trimester of pregnancy. Ultrasound Obstet Gynecol 1997; 11: 209-13. (Pubitemid 28190974)
4. Matias A, Gomes C, Flack N, Montenegro N, Nicolaides KH,. Screening for chromosomal abnormalities at 10-14 weeks: the role of ductus venosus blood flow. Ultrasound Obstet Gynecol 1998; 12: 380-4. (Pubitemid 29034205)
5. Hyett JA, Moscoso G, Papanagiotu G, Perdu M, Nicolaides KH,. Abnormalities of the great arteries in chromosomally normal fetuses with increased nuchal translucency thickness at 11-13 weeks of gestation. Ultrasound Obstet Gynecol 1996; 7: 245-50. (Pubitemid 126720343)
6. Hyett J, Perdu M, Sharland G, Snijders R, Nikolaides KH,. Screening for major congenital cardiac defects with fetal nuchal translucency at 10-14 weeks of gestation. Population based cohort study. BMJ 1999; 318: 81-5. (Pubitemid 29188923)
7. Makrydimas G, Sotiriadis A, Ioannidis JP,. Screening performance of first-trimester nuchal translucency for major cardiac defects: a meta-analysis. Am J Obstet Gynecol 2003; 189: 1330-5. (Pubitemid 37542168)
8. Ozcan T, Sbracia M, d'Ancona RL, Copel JA, Mari G,. Arterial and venous Doppler velocimetry in the severely growth-restricted fetus and associations with adverse perinatal outcome. Ultrasound Obstet Gynecol 1998; 12: 39-44. (Pubitemid 28379289)
9. Ritter S, Jörn H, Weiss C, Rath W,. Importance of Ductus venosus Doppler assessment for fetal outcome in cases of intrauterine growth restriction. Fetal Diagn Ther 2004; 19: 348-55. (Pubitemid 38822756)
10. Mavrides E, Sairam S, Hollis B, Thilaganathan B,. Screening for aneuploidy in the first trimester by assessment of blood flow in the ductus venosus. BJOG 2002; 109: 1015-9. (Pubitemid 35279132)
11. Antolin E, Comas C, Torrents M, Munoz A, Figueras F, Echevarria M, et al., The role of ductus venosus blood flow assessment in screening for chromosomal abnormalities at 10-16 weeks of gestation. Ultrasound Obstet Gynecol 2001; 17: 295-300. (Pubitemid 32417442)
12. Matias A, Huggon I, Areias JC, Montenegro N, Nicolaides KH,. Cardiac defects in chromosomally normal fetuses with abnormal ductus venosus blood flow at 10-14 weeks. Ultrasound Obstet Gynecol 1999; 14: 307-10. (Pubitemid 30032352)
13. Favre R, Cherif Y, Kohler M, Kohler A, Hunsinger MC, Bouffet N, et al., The role of fetal nuchal translucency and ductus venosus Doppler at 11-14 weeks of gestation in the detection of major congenital heart defects. Ultrasound Obstet Gynecol 2003; 21: 239-43. (Pubitemid 36390708)
14. Nicolaides KH, Azar G, Byrne D, Mansur C, Marks K,. Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy. BMJ 1992; 304: 867-9.
15. Maiz N, Kagan KO, Milovanovic Z, Celik E, Nicolaides KH,. Learning curve for Doppler assessment of ductus venosus flow at 11 + 0 to 13 + 6 weeks. Ultrasound Obstet Gynecol 2008; 1: 256-60.
16. Chu H, Cole SR,. Bivariate meta-analysis of sensitivity and specificity with sparse data: a generalized linear mixed model approach. J Clin Epidemiol 2006; 59: 1331-2. (Pubitemid 44708615)
17. Chelemen T, Syngelaki A, Maiz N, Allan L, Nicolaides KH,. Contribution of ductus venosus doppler in first-trimester screening for major cardiac defects. Fetal Diagn Ther 2011; 29: 127-34.
18. Timmerman E, Clur SA, Pajkrt E, Bilardo CM,. First-trimester measurement of the ductus venosus pulsatility index and the prediction of congenital heart defects. Ultrasound Obstet Gynecol 2010; 36: 668-75.
19. Özer O, Sayin CN, Varol FG,. The assessment of nuchal translucency and serum markers for down syndrome screening with ductus venosus doppler measurements in the first trimester. [Down sendromu taramasinda birinci trimester nukal kalinlik ve serum belirteçlerinin duktus venozus doppler ölçümü ile deerlendirilmesi]. J Turkish German Gynecol Assoc 2010; 11: 194-8.
20. De Mooij YM, Haak MC, Bartelings MM, Twisk JW, Gittenberger-De Groot A, Van Vugt JMG, et al., Abnormal ductus venosus flow in first-trimester fetuses with increased nuchal translucency relationship with the type of cardiac defect? J Ultrasound Med 2010; 29: 1051-8.
21. Bas-Budecka E, Magorzata P, Piotr S,. The role of fetal nuchal translucency (NT) and ductus venosus blood flow (DV) in the detection of congenital heart defects. [Ocena przeziernoœci karkowej (NT) oraz spektrum przepywu w przewodzie ¿ylnym (DV) w wykrywaniu wad serca podu]. Ginekol Pol 2010; 81: 272-6.
22. Martínez JM, Comas M, Borrell A, Bennasar M, Gõmez O, Puerto B, et al., Abnormal first-trimester ductus venosus blood flow: a marker of cardiac defects in fetuses with normal karyotype and nuchal translucency. Ultrasound Obstet Gynecol 2010; 35: 267-72.
23. Maiz N, Valencia C, Emmanuel EE, Staboulidou I, Nicolaides KH,. Screening for adverse pregnancy outcome by ductus venosus Doppler at 11-13 + 6 weeks of gestation. Obstet Gynecol 2008; 112: 598-605.
24. Maiz N, Plasencia W, Dagklis T, Faros E, Nicolaides K,. Ductus venosus doppler in fetuses with cardiac defects and increased nuchal translucency thickness. Ultrasound Obstet Gynecol 2008; 31: 256-60.
25. Gollo CA, Murta CGV, Bussamra LC, Santana RM, Moron AF,. Predictive value for fetal outcome of doppler velocimetry of the ductus venosus between the 11th and the 14th gestation week. [Valor preditivo do resultado fetal da dopplervelocimetria de ducto venoso entre a 11a e a 14a semanas de gestação]. Rev Bras Ginecol Obstet 2008; 30: 5-11.
26. Oh C, Harman C, Baschat AA,. Abnormal first-trimester ductus venosus blood flow: a risk factor for adverse outcome in fetuses with normal nuchal translucency. Ultrasound Obstet Gynecol 2007; 30: 192-6. (Pubitemid 47266023)
27. Toyama JM, Brizot ML, Liao AW, Lopes LM, Nomura RMY, Saldanha FAT, et al., Ductus venosus blood flow assessment at 11 to 14 weeks of gestation and fetal outcome. Ultrasound Obstet Gynecol 2004; 23: 341-5. (Pubitemid 38530298)
28. Haak MC, Twisk JWR, Bartelings MM, Gittenberger-de Groot AC, Van Vugt JMG,. Ductus venosus flow velocities in relation to the cardiac defects in first-trimester fetuses with enlarged nuchal translucency. Am J Obstet Gynecol 2003; 188: 727-33. (Pubitemid 36332441)
29. Murta CGV, Moron AF, Avila MAP, Weiner CP,. Application of ductus venosus doppler velocimetry for the detection of fetal aneuploidy in the first trimester of pregnancy. Fetal Diagn Ther 2002; 17: 308-14.
30. Zoppi MA, Putzolu M, Ibba RM, Floris M, Monni G,. First-trimester ductus venosus velocimetry in relation to nuchal translucency thickness and fetal karyotype. Fetal Diagn Ther 2002; 17: 52-7. (Pubitemid 34102562)
31. Bilardo CM, Muller MA, Zikulnig L, Schipper M, Hecher K,. Ductus venosus studies in fetuses at high risk for chromosomal or heart abnormalities: relationship with nuchal translucency measurement and fetal outcome. Ultrasound Obstet Gynecol 2001; 17: 288-94. (Pubitemid 32417441)
32. Whiting PF, Weswood ME, Rutjes AW, Reitsma JB, Bossuyt PN, Kleijnen J,. Evaluation of QUADAS, a tool for the quality assessment of diagnostic accuracy studies. BMC Med Res Methodol 2006; 6: 9.
33. Clur SA, Ottenkamp J, Bilardo CM,. The nuchal translucency and the fetal heart: a literature review. Prenat Diagn 2009; 29: 739-48.
34. Jelliffe-Pawlowski LL, Walton-Haynes L, Currier RJ,. Identification of second trimester screen positive pregnancies at increased risk for congenital heart defects. Prenat Diagn 2009; 29: 570-7.